Last reviewed · How we verify
Candidiasis of skin
Approved treatments
- Lotrimin · Bayer AG
- Abelcet · Astellas Pharma
- Viniconazole
Viniconazole works by inhibiting the growth of fungi. - Mycostatin · Generic (originally Squibb)
- OMOCONAZOLE
Omoconazole works by inhibiting the growth of fungal cells. - Spectazole
Spectazole works by inhibiting the enzyme lanosterol 14α-demethylase, which is necessary for fungal cells to produce ergosterol, a critical component of their cell membranes. - Rodinolone
- Monistat · Johnson & Johnson (Janssen)
- Nizoral · Johnson & Johnson (Janssen)
- Loprox · Bausch Health
- Penlac · 9305-9954 Quebec Inc
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Candidiasis of skin patent landscape — cliff calendar, originator estates, attackable patents
- Candidiasis of skin treatment landscape brief
- Candidiasis of skin treatment updates RSS
Frequently asked questions about Candidiasis of skin
What drugs treat Candidiasis of skin?
Tracked treatments include Lotrimin, Abelcet, Viniconazole, Mycostatin, OMOCONAZOLE, Spectazole, Rodinolone, Monistat.
What is the treatment for Candidiasis of skin?
Standard treatment for Candidiasis of skin includes Lotrimin, Abelcet, Viniconazole, Mycostatin, OMOCONAZOLE. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Candidiasis of skin patent cliff · Candidiasis of skin CI report
- Treatment: Lotrimin · Bayer AG
- Treatment: Abelcet · Astellas Pharma
- Treatment: Viniconazole
- Treatment: Mycostatin · Generic (originally Squibb)
- Treatment: OMOCONAZOLE
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing